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Abstract
 
The ability to regulate specific genes of energy metabolism
in response to fasting and feeding is an important adapta-
tion allowing survival of intermittent food supplies. How-
ever, little is known about transcription factors involved in
such responses in higher organisms. We show here that gene
expression in adipose tissue for adipocyte determination
differentiation dependent factor (ADD) 1/sterol regulatory
element binding protein (SREBP) 1, a basic-helix-loop-helix
protein that has a dual DNA-binding specificity, is reduced
dramatically upon fasting and elevated upon refeeding; this
parallels closely the regulation of two adipose cell genes that
are crucial in energy homeostasis, fatty acid synthetase
(FAS) and leptin. This elevation of ADD1/SREBP1, leptin,
and FAS that is induced by feeding in vivo is mimicked by
exposure of cultured adipocytes to insulin, the classic hor-
mone of the fed state. We also show that the promoters for
both leptin and FAS are transactivated by ADD1/SREBP1.
A mutation in the basic domain of ADD1/SREBP1 that al-
lows E-box binding but destroys sterol regulatory element-1
binding prevents leptin gene transactivation but has no ef-
fect on the increase in FAS promoter function. Molecular
dissection of the FAS promoter shows that most if not all of
this action of ADD1/SREBP1 is through an E-box motif at
 
2
 
64 to 
 
2
 
59, contained with a sequence identified previ-
ously as the major insulin response element of this gene.
These results indicate that ADD1/SREBP1 is a key tran-
scription factor linking changes in nutritional status and in-
sulin levels to the expression of certain genes that regulate
 
systemic energy metabolism. (
 
J. Clin. Invest.
 
 
 
1998. 101:1–9.)
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Introduction
 
Mammals and other higher species have evolved complex
mechanisms to maintain a constant supply of metabolic energy
in the face of highly variable food supplies. Adipose tissue is
the primary site of energy storage, building triglycerides in
times of nutritional excess and releasing this energy in the
form of FFA and glycerol in times of fasting. The ability to
carry out these functions efficiently is dependent on changes in
the expression of genes that carry out the lipogenic or lipolytic
programs. The adipose depot is not an entirely passive player
in this energy homeostasis scheme; adipose cells can secrete
molecules that limit obesity through effects on food intake and
energy expenditure (leptin; reference 1) and control insulin
sensitivity of other tissues (TNF-
 
a
 
; references 2 and 3).
Despite the fact that changes in gene expression are an im-
portant component in the response of adipose and other tis-
sues to altered nutritional states, the precise mechanisms re-
sponsible for this are not known. Several response elements at
the DNA level have been described for glucose or insulin-
dependent regulation (4, 5), but no transcription factors play-
ing well-defined roles have been identified. One interesting
candidate could be adipocyte determination differentiation de-
pendent factor (ADD) 1/sterol regulatory element binding
 
protein (SREBP)
 
1
 
 1. This transcription factor, cloned origi-
nally from rat adipose tissue (6), has been shown to regulate
the expression of several key genes of fatty acid and triglycer-
ide metabolism in cultured fibroblasts, adipocytes, and the liv-
ers of transgenic mice (7–9). Fatty acid synthetase (FAS), in
particular, has been shown to be regulatable by ADD1/
SREBP1 (7, 8, 10) and sensitive to nutritional perturbations in
vivo (11, 12). The human homolog of ADD1 (SREBP1) and a
closely related factor (SREBP2) have been cloned indepen-
dently and shown to be associated with the regulation of sev-
eral genes controlling cholesterol homeostasis (13, 14). Nota-
bly, depletion of cholesterol causes proteolytic release of the
transcriptionally active amino-terminal portion of these mole-
cules from their position embedded in the endoplasmic reticu-
lum membrane to allow movement to the nucleus (15, 16).
Based on a range of data generated in vivo and in cultured
cells, it is likely that SREBP2 is associated more specifically
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with cholesterol metabolism, while ADD1/SREBP1 plays a
major role in the control of genes involved in metabolism of
fatty acids and other lipids (7, 8, 17, 18).
ADD1/SREBP1 is very unusual in that it has a dual DNA-
binding specificity (19). Like most members of the basic-helix-
loop-helix (bHLH) family, it can bind to E-box sequences hav-
ing a consensus CANNTG (20). However, unlike any other
member of this family, it also binds the sterol regulatory ele-
ment (SRE)-1 sequence (ATCACCCCAC), first associated
with genes of cholesterol metabolism (21, 22). This dual DNA-
binding specificity of ADD1/SREBP1 is due entirely to an
atypical tyrosine in the basic DNA-binding domain, where all
other bHLH factors have an arginine (19). These DNA-bind-
ing characteristics are noteworthy because several (but not all)
identified insulin response elements appear to be E-boxes, in-
cluding one in the FAS promoter (4, 23).
In this study, we show that the expression of ADD1/
SREBP1 is altered dramatically during fasting and refeeding
of mice, closely paralleling the regulation of two key genes of
energy homeostasis, FAS and leptin. ADD1/SREBP1 transac-
tivates both of these promoters, regulating FAS primarily
through its identified insulin response element. These data
identify ADD1/SREBP1 as an important transcriptional regu-
lator of adipose cell genes sensitive to nutritional status and in-
sulin.
 
Methods
 
Animal treatment.
 
Female C57BL/6 mice (10–12 wk, 18–22 g) were
housed (five mice/cage) and raised on open formula rat/mouse ra-
tions (Zeigler Brothers, Inc., Gardners, PA), and water was given ad
libitum, with a 12-h light–dark cycle beginning at 6:30 a.m. All experi-
ments were conducted in compliance with the guidelines of the Ani-
mal Care and Use Committee of the National Institutes of Health. In
experiments, food was withdrawn during the daylight hours before
onset of the dark cycle. In the refeeding experiment, food was rein-
troduced after 7.5 h of fasting. Animals were killed at indicated time
points for the isolation of epididymal fat.
 
Northern blot analysis and RNase protection assay.
 
Total RNA
was isolated from the epididymal adipose tissue of mice and cultured
cells by a guanidine isothiocyanate extraction protocol described pre-
viously (6, 7). 10–30 
 
m
 
g of RNA was denatured in formamide and
formaldehyde, and subsequently separated by electrophoresis in
formaldehyde-containing agarose gels. RNA was transferred to nylon
membrane (ICN Biomedicals, Inc., Costa Mesa, CA), and membranes
were cross-linked, hybridized, and washed as described by the manu-
facturer. DNA probes were labeled with [
 
a
 
-
 
32
 
P]dCTP (6,000 Ci/mmol)
with a random primer labeling kit (Boehringer Mannheim Biochemi-
cals, Indianapolis, IN). The cDNA containing the sequence corre-
sponding to murine SREBP1a mRNA (
 
2
 
102 to 
 
1
 
200; nucleotide 1 is
the A of the ATG codon that encodes the first methionine) was
cloned by PCR. The amplified cDNA was subcloned into pGEM-
7Zf(
 
1
 
) (Promega Corp., Madison, WI). After linearization of plas-
mid DNA, antisense RNA was transcribed with [
 
a
 
-
 
32
 
P]UTP using T7
RNA polymerase (Ambion Inc., Austin, TX). RNase protection as-
says were performed with an RPA II kit (Ambion Inc.) as recom-
mended by the manufacturer. Briefly, sample RNA (5 or 10 
 
m
 
g) was
mixed with the 
 
32
 
P-labeled riboprobe in a hybridization buffer, and
the mixtures were denatured and hybridized. After digestion with
RNase A/T1, protected fragments were separated on a 6% polyacryl-
amide gel containing 8 M urea. Gels were dried and then subjected to
autoradiography.
 
Cell culture.
 
3T3-L1 preadipocytes were grown in DME contain-
ing 10% bovine calf serum. Differentiation of 3T3-L1 cells was in-
duced as described previously (24). At confluence, the medium was
 
changed to DME supplemented with 10% FBS, 1 
 
m
 
M dexametha-
sone, 0.5 mM isobutylmethyl xanthine, and 5 
 
m
 
g/ml of insulin for 2 d.
Thereafter, the medium was replaced every other day with 5 
 
m
 
g/ml of
insulin and 10% FBS. Rat1-IR cells were grown in DME/F12 (50:50)
medium containing 10% FBS as described previously (25).
 
Transient transfections and enzyme assays.
 
Rat1-IR cells were
cultured as described above and transfected 1 d before confluence
by the calcium phosphate method described previously (25). To ex-
amine insulin effects on the FAS promoter, transfected Rat1-IR cells
were incubated in 0.5% BSA (ICN Biomedicals, Inc.) overnight. The
following day, these serum-deprived cells were treated with insulin
(100 nM) for 24 h. Cells were then harvested for enzyme assays. All
the mammalian expression vectors for ADD1-403, ADD1-403R, and
CCAAT-enhancer–binding protein (C/EBP)
 
a
 
 are derived from pSV-
SPORT1 (GIBCO BRL, Gaithersburg, MD). Each 60-mm-diameter
dish received either 1 
 
m
 
g of luciferase reporter plasmid with rat FAS
promoter (
 
2
 
220 to 
 
1
 
25) or chloramphenicol acetyltransferase (CAT)
reporter plasmid with mouse leptin promoter (
 
2
 
6.5 kb to 
 
1
 
9) (Gen-
Bank accession number U65742). In addition, each dish received 0.5 
 
m
 
g
of pCH110 plasmid containing the lacZ gene (Pharmacia Biotech)
and either ADD1 (1 
 
m
 
g) or C/EBP
 
a
 
 (1 
 
m
 
g) expression vectors. The
level of CAT expression was determined by measuring CAT enzyme
activity as described previously (19). Luciferase activity was mea-
sured in a luminometer with a luciferin reagent (Boehringer Mann-
heim Biochemicals). 
 
b
 
-Galactosidase assays were performed by a
standard colorimetric procedure with chlorophenol red–
 
b
 
-
 
D
 
-galacto-
pyranoside as substrate (Boehringer Mannheim Biochemicals). The
relative CAT and luciferase activities were normalized to the 
 
b
 
-galac-
tosidase activity. All the transfection experiments were performed in
duplicate and repeated at least three times independently.
 
Electrophoretic mobility shift assay and plasmids.
 
EMSAs were
performed as described (19). In vitro–translated ADD1-403 and
ADD1-403R proteins were produced using the TNT SP6-coupled
reticulocyte lysate system (Promega Corp.). For binding assays, reac-
tions were carried out in 20-
 
m
 
l volume containing in vitro–translated
protein lysate (1–5 
 
m
 
l) and 
 
32
 
P-labeled probe (0.1 pmol). DNA–pro-
tein complexes were resolved on a 5% polyacrylamide gel. The gel
was dried and exposed to film at 
 
2
 
70
 
8
 
C. The FAS promoter muta-
tions described in the citations to Fig. 6 were generated by ligation of
three synthetic oligonucleotides. The DNA sequence of the wild-type
and mutant FAS promoter constructs was confirmed by DNA se-
quencing analysis, and subsequently cloned into a plasmid containing
a luciferase reporter gene.
 
Results
 
Nutritional and insulin regulation of ADD1/SREBP1 gene ex-
pression.
 
A uniform, synchronized feeding state was estab-
lished by removing food during the daylight hours, when mice
usually do not feed extensively. At the start of the night cycle
(6:30 p.m.), animals were either provided with food or de-
prived of food for 7.5 or 12 h. A fourth group of mice was refed
for 4.5 h after the 7.5-h fast. As can be seen in Fig. 1, 
 
A
 
 and 
 
B
 
,
ADD1, leptin, and FAS mRNA expression decreased dramat-
ically after the 7.5- or 12-h fast, and refeeding rapidly restored
these to a level equal to or exceeding the original fed state.
The maximal decrease was 90% for ADD1 and leptin and
75% for FAS. In contrast, mRNA for other important fat cell
transcriptional regulators such as peroxisome proliferator–
activated receptor 
 
g
 
 and C/EBP
 
a
 
 showed little change during
this relatively short-term fast. Lipoprotein lipase (LPL) mRNA
also underwent little alteration during these treatments. As il-
lustrated in Fig. 1 
 
B
 
, the decreases in ADD1, leptin, and FAS
are similar in relative magnitude and time course, suggesting
parallel regulation. In data not shown, we have found that sim-
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ilar regulation of ADD1/SREBP1 mRNA by fasting and re-
feeding is seen in the liver.
The particular hormones or nutrients responsible for this
response to fasting and feeding are of considerable interest.
Since insulin is the classic hormone of the fed state, and FAS
and leptin have been shown previously to be induced by insu-
lin (26, 27), we asked whether this hormone controls ADD1
expression in a parallel fashion. Indeed, insulin treatment at
100 nM increases ADD1 expression after 2 h, and this contin-
ues to increase until 6 h (Fig. 2 
 
A
 
). Leptin and FAS mRNAs
show similar increases, though as published previously, the lev-
els of leptin mRNA are very low in these cultured fat cells (11,
26–28).
Since insulin can function through its own receptor or, at
very high doses, through the IGF-1 receptor, an insulin dose–
response experiment was performed at a single time point (24 h).
As shown in Fig. 2 
 
B
 
, ADD1 expression is maximal at 10 nM
and then decreases somewhat at higher doses. This mirrors
closely the levels of FAS mRNA expression, while leptin ex-
pression appears relatively similar for doses between 2 and
Figure 1. Nutritional regulation of ADD1, FAS, and leptin gene expression. (A) mRNA expression levels in adipose tissue from fed and fasted 
mice were compared by Northern blot analysis. Mice were killed at different time points, and total RNA was prepared from epididymal adipose 
tissue. Mice were divided into four groups. A fed control (Fed) was allowed free access to food for 7.5 h (lane 1). Both fasted groups (Fast1 and 
Fast2) were denied access to food for 7.5 and 12 h, respectively (lanes 2 and 3). The refed group (Fast1/Refed) was allowed free access to food for 
4.5 h after 7.5 h of fasting (lane 4). Equivalent amounts (10 mg) of loaded RNA were run in each lane. (B) Quantitation of feeding and fasting ef-
fects. All the expression levels were normalized to b-actin gene expression. Expression of each gene was plotted relative to the control fed mice.
Figure 2. Insulin induction of ADD1 
mRNA. (A) Alteration of gene expression 
induced by insulin treatment. Fully differ-
entiated 3T3-L1 adipocytes were incu-
bated for 2 d in serum-free low glucose 
DME containing 0.5% BSA, and were 
then treated with 100 nM insulin. Cells 
were harvested at various time points to 
prepare total RNA. (B) Dose–response of 
insulin-induced gene expression. Fully dif-
ferentiated 3T3-L1 adipocytes were incu-
bated for 2 d in serum-free low glucose 
DME with 0.5% BSA. Adipocytes were 
then treated with or without insulin at a 
concentration range of 2–1,000 nM for
24 h. Cells were harvested to prepare total 
RNA (30 mg) for Northern blot analysis. 
Equivalent amounts of loaded RNA were 
run in each lane, as indicated by hybridiza-
tion to 36B4 probe.
 4
 
Kim et al.
 
1,000 nM. The relatively low amount of insulin required for
ADD1 expression is consistent with an action through the in-
sulin receptor (29). The lack of exact parallel between expres-
sion of ADD1/SREBP1 and leptin suggests that other tran-
scription factors besides or in addition to this one may be
important in insulin regulation of the leptin gene.
ADD1/SREBP1 mRNA has been shown to exist in two
forms generated by alternative splicing, differing in their 5
 
9
 
termini. ADD1, equivalent to SREBP1c, has been shown to be
the major form of mRNA expressed in adipose tissue in vivo
(30). To investigate which form of ADD1/SREBP1 is regu-
lated by nutritional status and insulin, we used an RNase pro-
tection assay, which can detect both splicing variants. In agree-
ment with Shimano and colleagues (30), ADD1/SREBP1c is
the major form of this gene expressed in white and brown fat,
while SREBP1a represents a significant portion of total tran-
scripts from lung, spleen, and thymus (Fig. 3 
 
B
 
). Fig. 3 
 
C
 
 illus-
trates that the ADD1/SREBP1c form is also the major form
regulated by fasting/refeeding in white adipose tissue. It ap-
pears to be the major splicing variant seen in cultured 3T3-L1
adipocytes, and is induced by insulin treatment of cultured adi-
pocytes (Fig. 3 
 
D
 
). The very low level of SREBP1a expressed
in fat tissue in vivo or in cultured adipocytes did not allow us to
determine whether it too is regulated.
 
ADD1/SREBP1 transactivates the FAS and leptin genes.
 
To investigate the potential of ADD1/SREBP1 to regulate the
FAS and leptin genes, promoter fragments were obtained and
linked to reporter genes luciferase or CAT. We used two al-
leles of ADD1 — one encoding the amino-terminal fragment
of the wild-type protein that has maximal activity (ADD1-
403), and a second that is similar except it contains a tyrosine
to arginine mutation at position 320 amino acid (termed
ADD1-403R). This mutation has been shown to disrupt the
dual specificity of DNA binding, allowing unaltered binding to
E-boxes but destroying completely binding to SRE motifs
(19). Fig. 4 
 
A
 
 shows that cotransfection of the wild-type 1–403
ADD1 allele with a 
 
2
 
220 to 
 
1
 
25–bp fragment of the FAS pro-
moter results in a fivefold stimulation of activity. Interestingly,
the ADD1-403R mutant allele does not reduce this transacti-
vation at all, suggesting that the response element(s) in the
FAS promoter is an E-box motif. The wild-type allele of
ADD1 strongly transactivates the leptin promoter (Fig. 4 
 
B
 
)
Figure 3. Nutrition and insulin regulation of 
ADD1/SREBP1 splicing variants. (A) Genomic 
structure of ADD1/SREBP1 gene. SREBP1a and 
ADD1/SREBP1c mRNAs are produced by alter-
nate splicing of the first two exons in the ADD1/
SREBP1 gene. RNase protection assays generate 
two different sizes (z 320 and z 128 bp) of 
SREBP1a and ADD1/SREBP1c transcripts, re-
spectively. (B) Expression pattern of ADD1/
SREBP1 transcripts from mouse tissues. WF, 
White fat. BF, Brown fat. H, Heart. Lu, Lung. Li, 
Liver. K, Kidney. Sp, Spleen. Br, Brain. M, Mus-
cle. Th, Thymus. (C) Effects of fasting and refeed-
ing on the ADD1/SREBP1 form in white fat. (D) 
Insulin regulation of ADD1/SREBP1 forms in 
cultured adipocytes. RNAs used in C and D were 
the same as those used in Fig. 1 A and Fig. 2 A, re-
spectively. RNase protection assays were per-
formed as described in Methods.
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by more than 12-fold. As has been shown previously, this pro-
moter also responds to C/EBP
 
a
 
 (31, 32). In contrast to the re-
sults with the FAS promoter, the Y
 
fi
 
R mutation at position
320 essentially prevents completely the transactivation of the
leptin gene by ADD1. This suggests that an E-box target is not
sufficient for transactivation, most likely implicating an SRE-
type element in the leptin promoter.
 
The ADD1/SREBP1 response element in FAS is an identi-
fied insulin response element E-box.
 
We have studied the sites
where ADD1/SREBP1 binds and functions on the FAS pro-
Figure 4. ADD1 transactivates the promoters of the FAS and leptin genes. (A) Ectopic expression of ADD1 activates the promoter of the FAS 
gene. Rat1-IR cells were cotransfected with FAS–luciferase reporter containing the FAS promoter (2220 to 125) and either wild-type ADD1 or 
ADD1-403 mutant expression vectors. Relative luciferase activity was calculated by normalization to b-galactosidase activity driven by pSV-
SPORT1 control vector. (B) Ectopic expression of ADD1 activates the promoter of the leptin gene. Rat1-IR cells were cotransfected with the 
leptin–CAT construct containing the leptin promoter (26.5 kb to 19) and several different expression vectors. Relative CAT activity was nor-
malized to b-galactosidase.
Figure 5. ADD1 binding 
sites in the FAS promoter. 
EMSA was performed with 
in vitro–translated ADD1-
403 (A) or ADD1-403R 
(B) protein. The radiola-
beled probes were pre-
pared from oligonucleo-
tides containing the SRE-1 
sequence (FS, FAS–SRE 
probe) or the E-box se-
quence (FE, FAS–E-box 
probe). Among competi-
tor oligonucleotides, FS in-
dicates the SRE-1 motif of 
the FAS promoter, and FE 
indicates the oligonucle-
otide containing E-box mo-
tif of the FAS promoter. 
FSm and FEm, mutated FS 
and FE oligonucleotides, 
respectively. Competitor 
sequences are FS: gcgcgg-
gATCA CCCCAC-
cgacggc; FSm: gcgcgggAT-
TATCTCACcgacggc; FE: 
ctgtcagccCATGTGgcgtg-
gccg; FEm: ctgtcagc-
cTTTGTTgcgtggccg. Mu-
tated nucleotides are in 
bold. N.S., Nonspecific 
DNA–protein complex.
6 Kim et al.
moter. Visual and computer-assisted examination reveal two
potential ADD1/SREBP1 binding sites, an SRE-1–type ele-
ment at 2150 to 2141, and an E-box at 264 to 259. This E-box
overlaps a sequence identified by Moustaid et al. as an insu-
lin response element in the FAS promoter (10, 23). Fig. 5 A
shows that in vitro–translated wild-type ADD1/SREBP1 binds
to both of these sequences when they are presented as 24-mers
in EMSA. We next investigated whether the Yfi R mutation
really distinguished E-box versus SRE binding at these pro-
moters, as we have shown previously on sequences from other
genes (19). Either oligonucleotide sequence (E-box or SRE-1)
can compete specifically for binding of this protein to the cog-
nate sequence or to the other binding sequence (Fig. 5 A). In
contrast, the tyrosine to arginine mutation at residue 320
(ADD1-403R) can bind to the E-box oligonucleotide, but
competition is only possible with the E-box sequence, not
with a mutated E-box or the SRE element from the FAS gene
(Fig. 5 B).
We next performed functional analysis of the FAS pro-
moter that has the potential ADD1/SREBP1 binding sites dis-
rupted sequentially or simultaneously by point mutations. In
addition, because of the effects of insulin on the expression of
endogenous ADD1/SREBP1 (Fig. 2), we have also used insu-
lin treatments to ask whether there might be any further post-
transcriptional effects of insulin on this protein. Fig. 6 A shows
that insulin treatment for 24 h causes an approximately three-
fold further increase in the activity that ectopically expressed
ADD1-403 elicits from the FAS promoter. The ADD1-403R
mutant shows an identical effect.
Mutation first of the SRE sequence at 2150 to 2141 did
not diminish the response to ADD1/SREBP1, with or without
insulin (Fig. 6 B). In contrast, mutation of the E-box at posi-
tion 264 to 259 had two effects: it decreased overall activity of
the promoter by 80%, and it completely ablated the effect of
added insulin (Fig. 6 B). A double mutation of the SRE and
E-box renders this promoter completely resistant to activation
by ADD1/SREBP1. These data indicate that most of the trans-
activation of this FAS promoter by ADD1/SREBP1 goes
through the E-box motif at position 264 to 259. These data
indicate a clear linkage between the nutrition and insulin regu-
lation of ADD1/SREBP1 shown here and the E-box sequence
identified as an insulin response element in the FAS promoter.
Figure 6. Mutational analysis of ADD1 action on 
the FAS promoter. (A) Rat1-IR cells were 
cotransfected with FAS–luciferase (Luc) con-
struct containing FAS promoter, pCH110 b-galac-
tosidase plasmid, and different ADD1 expression 
vectors. After transfections, cells were incubated 
overnight in serum-free DME with 0.5% BSA, 
and were then treated with (black bars) or with-
out 100 nM insulin (white bars) for 24 h. Trans-
fected cells were harvested and assayed for lu-
ciferase and b-galactosidase activity. (B) Various 
FAS–luciferase constructs containing mutations 
in either the SRE-1 or E-box were generated as 
described in Methods. Rat1-IR cells were cotrans-
fected with each promoter fragment linked to lu-
ciferase with or without ADD1 expression vec-
tors. After transfections, cells were treated as 
described above, and enzyme assays were per-
formed. S/E-FAS-Luc, Reporter containing both 
wild-type SRE-1 and E-box motifs. mS/E-FAS-
Luc, Reporter containing mutated SRE-1 and 
wild-type E-box motifs. S/mE-FAS-Luc, Reporter 
containing wild-type SRE-1 and mutated E-box 
motifs. mS/mE-FAS-Luc, Reporter containing 
mutations in both SRE-1 and E-box motifs. All 
the mutated sequences are described in the leg-
end to Fig. 5.
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Discussion
The last 10 years have seen a vast increase in our knowledge of
how nutrients and hormones controlled by diet can influence
gene expression. The classic hormones of the fasted state, cate-
cholamines and glucagon, function by raising cAMP levels,
which can result in the activation of the transcription factor
cAMP response element–binding protein through protein ki-
nase A (33). This factor then functions in a variety of fasting-
sensitive genes through a canonical cAMP response element–
binding protein binding site. Fasting also leads to an elevation
of glucocorticoids, which control gene expression mainly if not
exclusively through the glucocorticoid receptor and its well-
defined cognate sequence (34, 35).
The control of gene expression by feeding and the major
feeding-associated hormone, insulin, have been more difficult
to understand. Many insulin-sensitive genes have been stud-
ied, and there is little consensus as to what an insulin response
element looks like (4). Even less is known about transcription
factors that respond to insulin and regulate important genes of
lipid and carbohydrate metabolism.
For a transcription factor to be described as an insulin re-
sponse factor, several key criteria must be satisfied. First, it
must participate in the regulation of the insulin-regulated tar-
get gene in question, as illustrated through ectopic expression
(gain of function) or loss-of-function experiments in cells or
whole animals. Second, the activity of the transcription factor
itself must be regulated directly or indirectly by insulin. Fi-
nally, the target DNA sequence to which the gene control fac-
tor binds must be characterized. The work presented in this
paper, in combination with previously published work from
our laboratory and others (7, 8, 10, 23), establishes ADD1/
SREBP1c as the first or among the first bona fide insulin re-
sponse transcription factors.
Endogenous FAS expression has been shown previously to
respond to changes in feeding status and insulin levels (11, 26).
As shown in cultured cells and the livers of transgenic mice,
ectopic expression of ADD1/SREBP1 alone is sufficient to
increase greatly the expression of FAS and several other lipo-
genic genes (7, 8, 36). In cultured fibroblasts, the levels of ec-
topic ADD1/SREBP1 mRNA that can activate FAS expres-
sion are no greater than those normally expressed in cultured
adipose cells or adipose tissue.
In the work presented here, insulin regulates ADD1/
SREBP1 on at least two levels. It increases greatly its expres-
sion at the mRNA level and does so at doses of insulin consis-
tent with a function through the insulin receptor. The dramatic
regulation of ADD1/SREBP1 expression in adipose tissue ob-
served during fasting and refeeding is consistent with this find-
ing. Of course, it is entirely possible that other hormones or
nutrients in addition to insulin participate in the regulation of
ADD1/SREBP1 in this in vivo context. As shown in Fig. 6,
ADD1/SREBP1 expressed by a viral promoter is also acti-
vated by the exposure of cells to insulin, suggesting an addi-
tional posttranscriptional activation. This has also been sug-
gested by the experiments of Streicher et al., who examined
the effects of insulin and IGF-1 in the LDL receptor gene (37).
Finally, the effects of ADD1/SREBP1 on the FAS pro-
moter could be associated clearly with one particular target se-
quence, the E-box at 264 to 259. This is especially interesting
because Sul and colleagues have identified a longer sequence
that contains this element as the response element of FAS to
insulin, in their studies performed in cultured adipocytes (23).
When these various studies are combined, it is clear that
ADD1/SREBP1 is functioning as an insulin response factor, at
least in adipose tissue. Of course, further determination of the
relative importance of this factor in the regulation of FAS, lep-
tin, and other adipose-cell genes must await loss-of-function
experiments involving genetic ablation of ADD1/SREBP1 in
various tissues. Although our studies have focused primarily
on fat tissue, the high levels of expression of ADD1/SREBP1
in liver suggest that this molecule could also be involved in the
control of certain insulin-responsive genes in this tissue. On
the other hand, Wang and Sul (in 1996) have suggested that
upstream stimulatory factor 1, another member of the bHLH
family, may be involved at the same key E-box control ele-
ment in the liver (38). To date, there is no data indicating that
ectopic expression of this factor can regulate FAS expression.
Further studies will be required to clarify this point.
Despite the evidence that ADD1/SREBP1 can bind well to
E-box sequences, it has been suggested recently that all or
nearly all of the responses to the SREBPs were through SRE-
type elements (39). Several lines of evidence now argue strongly
for a function of ADD1 in the FAS promoter through the
E-box. First, a mutant of ADD1/SREBP1 which can bind to
E-boxes but not to SREs can transactivate the FAS promoter
as well as the wild-type allele (Figs. 4 and 5). Second, specific
mutations of the FAS promoter show that most if not all activ-
ity goes through the E-box at position 264 to 259 (Fig. 6). Fi-
nally, we have found most recently that the Yfi R mutation of
ADD1/SREBP1, targeted only to E-boxes, activates FAS gene
expression effectively when ectopically expressed in fibro-
blasts (data not shown). Hence, the E-box motif must be con-
sidered the primary target of ADD1/SREBP1, at least for the
FAS gene.
Feeding status has two important effects on adipose cells: it
controls the amount of lipid in each cell, and can also affect the
number of adipose cells. Most obesity generally involves an in-
crease in both cell size and cell number. The data presented
here and in earlier reports suggest that ADD1/SREBP1 may
represent a plausible mechanism unifying both of these aspects
of adipose cell biology (Fig. 7). While this factor alone is not
sufficient to drive adipogenesis efficiently in fibroblasts, it can
increase the percentage of cells that differentiate into adipo-
cytes in response to a cocktail of inducing hormones (7). It ap-
pears to do this, at least in part, by increasing the transcrip-
tional activity elicited from the adipogenic nuclear receptor
Figure 7. Role of ADD1/SREBP1 in lipogenesis and adipogenesis.
8 Kim et al.
peroxisome proliferator–activated receptor g, perhaps through
the generation of an endogenous ligand. Hence, chronic over-
feeding and its attending elevation of insulin would be ex-
pected to result in increased expression and activity of ADD1/
SREBP1. This is likely to affect both lipid accumulation in fat
cells through increased expression of FAS, LPL, and other li-
pogenic genes, and more differentiation of adipocytes from
precursor cells. Fig. 7 also illustrates that a possible effect on
leptin expression could assert feedback regulation to the con-
trol of food intake. However, since there are no experiments
yet illustrating that ADD1/SREBP1 can regulate endogenous
leptin gene, this must be considered speculative.
Several interesting questions concerning the regulation of
ADD1/SREBP1 by insulin remain. The robust regulation of this
gene by feeding status and insulin suggests that other factors
upstream of ADD1/SREBP1, as yet undefined, must be influ-
enced by nutrients and hormones at the transcriptional and/or
posttranscriptional levels. Second, there appears to be a mech-
anism for posttranscriptional regulation of ADD1/SREBP1
activity by insulin (Fig. 6, and reference 37). We have found re-
cently that ADD1/SREBP1 is phosphorylated on serine resi-
due(s) in response to insulin (our unpublished data). Whether
this phosphorylation plays a role in the alteration of ADD1 ac-
tivity remains to be determined.
A final question relates to the proteolytic processing of
ADD1/SREBP1. This factor can be activated proteolytically
on cultured fibroblasts in response to cholesterol depletion
(15, 40, and references therein). For the endogenous protein to
work effectively, it seems likely that there must be some means
of removing it from the endoplasmic reticulum of fat tissue, as
has been shown for the liver. However, since ADD1/SREBP1
expression is induced by feeding and reduced dramatically in
fasting, paradoxical to what might be expected for a factor ac-
tivated proteolytically by cholesterol depletion, it seems very
likely that there are somewhat different mechanisms to acti-
vate this protein in fat. This could conceivably be through pro-
teolysis linked to other signals, such as the levels of insulin or
fatty acids, or this could conceivably involve escape from en-
doplasmic reticulum insertion through masking specifically the
hydrophobic domain in the middle of ADD1/SREBP1. Fur-
ther studies must address this question.
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